MedTrace Logo

Investigating Genetic Risk for Type 1 Diabetes

NCT03503747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15640

Last updated 2021-09-24

No results posted yet for this study

Summary

The objective of this study is to determine the percentage of children with genetic markers putting them at increased risk of developing type 1 diabetes, and to offer the opportunity for these children to be enrolled into a phase II b primary prevention trial.

Conditions

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Eligibility

Min Age
0 Months
Max Age
4 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03503747 on ClinicalTrials.gov